Replies to post #1361 on Vascular Biogenics Ltd (VBLT)

[Jumpinjackas]

One more patient from trial.

https://www.facebook.com/groups/237985362899868/permalink/1262198963811831/

Started on VB111 10/26 - passed away 5/2017

[staccani]

Jump, please stop posting these. Provided that we expect as avg 50%-60% survive 1 year on VBL111, 1-2 cases specific deceased patients do not tell us anything about VBL111 efficacy. Moreover it is not even clear if they were on the VBL111 arm